MBrace Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors (NCT07145255) | MBrace Therapeutics | 2025-09-03 |
| Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors (NCT06014658) | MBrace Therapeutics | 2023-11-07 |
Track MBrace Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.